Asahi Intecc Co., Ltd. (AHICF)
USD 16.17
(0.0%)
USD 16.17
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 69.05 Billion JPY | 17.37% |
| 2023 | 58.83 Billion JPY | 15.17% |
| 2022 | 51.08 Billion JPY | 23.18% |
| 2021 | 41.46 Billion JPY | 9.02% |
| 2020 | 38.03 Billion JPY | -4.19% |
| 2019 | 39.7 Billion JPY | 13.9% |
| 2018 | 34.85 Billion JPY | 22.62% |
| 2017 | 28.42 Billion JPY | 9.69% |
| 2016 | 25.91 Billion JPY | 16.68% |
| 2015 | 22.21 Billion JPY | 23.95% |
| 2014 | 17.91 Billion JPY | 32.63% |
| 2013 | 13.51 Billion JPY | 36.15% |
| 2012 | 9.92 Billion JPY | -7.04% |
| 2011 | 10.67 Billion JPY | 23.03% |
| 2010 | 8.67 Billion JPY | 25.96% |
| 2009 | 6.88 Billion JPY | 17.43% |
| 2008 | 5.86 Billion JPY | -11.7% |
| 2007 | 6.64 Billion JPY | 19.65% |
| 2006 | 5.55 Billion JPY | 25.43% |
| 2005 | 4.42 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 16.54 Billion JPY | -4.47% |
| 2024 Q3 | 17.31 Billion JPY | 4.54% |
| 2024 Q1 | 18.62 Billion JPY | 48.44% |
| 2024 Q2 | 16.56 Billion JPY | -11.06% |
| 2023 Q2 | 15.22 Billion JPY | 2.77% |
| 2023 FY | 58.83 Billion JPY | 15.17% |
| 2023 Q4 | 12.54 Billion JPY | -22.77% |
| 2023 Q1 | 14.81 Billion JPY | 10.66% |
| 2023 Q3 | 16.24 Billion JPY | 6.71% |
| 2022 Q4 | 13.38 Billion JPY | 5.67% |
| 2022 FY | 51.08 Billion JPY | 23.18% |
| 2022 Q3 | 12.67 Billion JPY | -2.88% |
| 2022 Q2 | 13.04 Billion JPY | 8.92% |
| 2022 Q1 | 11.97 Billion JPY | 8.73% |
| 2021 Q3 | 10.93 Billion JPY | 15.05% |
| 2021 Q4 | 11.01 Billion JPY | 0.76% |
| 2021 Q2 | 9.5 Billion JPY | -5.12% |
| 2021 FY | 41.46 Billion JPY | 9.02% |
| 2021 Q1 | 10.01 Billion JPY | 43.71% |
| 2020 FY | 38.03 Billion JPY | -4.19% |
| 2020 Q4 | 6.96 Billion JPY | -29.71% |
| 2020 Q1 | 10.84 Billion JPY | 14.02% |
| 2020 Q2 | 10.3 Billion JPY | -4.93% |
| 2020 Q3 | 9.91 Billion JPY | -3.82% |
| 2019 FY | 39.7 Billion JPY | 13.9% |
| 2019 Q4 | 9.51 Billion JPY | -9.52% |
| 2019 Q3 | 10.51 Billion JPY | 7.7% |
| 2019 Q2 | 9.75 Billion JPY | -1.62% |
| 2019 Q1 | 9.91 Billion JPY | 23.19% |
| 2018 Q3 | 9.1 Billion JPY | 1.29% |
| 2018 Q2 | 8.98 Billion JPY | 3.22% |
| 2018 Q1 | 8.7 Billion JPY | 22.18% |
| 2018 Q4 | 8.05 Billion JPY | -11.56% |
| 2018 FY | 34.85 Billion JPY | 22.62% |
| 2017 Q3 | 7.65 Billion JPY | 12.08% |
| 2017 Q1 | 6.81 Billion JPY | 15.13% |
| 2017 Q4 | 7.12 Billion JPY | -6.86% |
| 2017 Q2 | 6.82 Billion JPY | 0.15% |
| 2017 FY | 28.42 Billion JPY | 9.69% |
| 2016 Q3 | 7 Billion JPY | 10.65% |
| 2016 Q1 | 6.66 Billion JPY | 15.77% |
| 2016 FY | 25.91 Billion JPY | 16.68% |
| 2016 Q4 | 5.92 Billion JPY | -15.41% |
| 2016 Q2 | 6.32 Billion JPY | -5.13% |
| 2015 Q4 | 5.76 Billion JPY | -0.51% |
| 2015 Q1 | 5.18 Billion JPY | 15.28% |
| 2015 FY | 22.21 Billion JPY | 23.95% |
| 2015 Q3 | 5.78 Billion JPY | 5.77% |
| 2015 Q2 | 5.47 Billion JPY | 5.51% |
| 2014 Q2 | 4.48 Billion JPY | 10.11% |
| 2014 Q3 | 4.86 Billion JPY | 8.59% |
| 2014 Q4 | 4.5 Billion JPY | -7.53% |
| 2014 FY | 17.91 Billion JPY | 32.63% |
| 2014 Q1 | 4.07 Billion JPY | 12.37% |
| 2013 Q2 | 3.34 Billion JPY | 3.96% |
| 2013 Q3 | 3.32 Billion JPY | -0.56% |
| 2013 Q4 | 3.62 Billion JPY | 8.9% |
| 2013 FY | 13.51 Billion JPY | 36.15% |
| 2013 Q1 | 3.21 Billion JPY | 33.78% |
| 2012 Q3 | 2.09 Billion JPY | -16.39% |
| 2012 Q1 | 2.92 Billion JPY | 14.12% |
| 2012 Q2 | 2.49 Billion JPY | -14.63% |
| 2012 FY | 9.92 Billion JPY | -7.04% |
| 2012 Q4 | 2.4 Billion JPY | 15.06% |
| 2011 Q3 | 2.88 Billion JPY | 13.54% |
| 2011 Q1 | 2.68 Billion JPY | 25.33% |
| 2011 FY | 10.67 Billion JPY | 23.03% |
| 2011 Q4 | 2.56 Billion JPY | -11.04% |
| 2011 Q2 | 2.54 Billion JPY | -5.37% |
| 2010 Q3 | 2.35 Billion JPY | 18.69% |
| 2010 FY | 8.67 Billion JPY | 25.96% |
| 2010 Q4 | 2.14 Billion JPY | -9.08% |
| 2010 Q1 | 2.19 Billion JPY | 16.8% |
| 2010 Q2 | 1.98 Billion JPY | -9.53% |
| 2009 Q1 | 1.65 Billion JPY | 0.0% |
| 2009 Q4 | 1.87 Billion JPY | 7.95% |
| 2009 Q3 | 1.74 Billion JPY | 7.99% |
| 2009 Q2 | 1.61 Billion JPY | -2.81% |
| 2009 FY | 6.88 Billion JPY | 17.43% |
| 2008 FY | 5.86 Billion JPY | -11.7% |
| 2007 FY | 6.64 Billion JPY | 19.65% |
| 2006 FY | 5.55 Billion JPY | 25.43% |
| 2005 FY | 4.42 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -4063976.012% |
| Ansell Limited | 624.8 Million USD | -10952.017% |
| Ansell Limited | 624.8 Million USD | -10952.017% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -60503.654% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -51129439.817% |
| Psykey, Inc. | 415.97 Thousand USD | -16600136.552% |
| ConvaTec Group Plc | 1.2 Billion USD | -5639.571% |
| ConvaTec Group Plc | 1.17 Billion USD | -5777.852% |
| Encision Inc. | 3.13 Million USD | -2201871.835% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -8696608.996% |
| LifePoint, Inc. | -71.35 Thousand USD | 96769908.571% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 52712313.74% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -13152852.381% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -11446919.428% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -11577795.48% |
| SmileDirectClub, Inc. | 275.84 Million USD | -24933.08% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -7566.347% |
| SheerVision, Inc. | 2.17 Million USD | -3173424.26% |
| United Health Products, Inc. | -4857.00 USD | 1421721327.095% |
| Vasamed, Inc. | -69.38 Thousand USD | 99517307.586% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -25798385.409% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -131149713.872% |